Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huatai Pharma
Qingdao, Shandong Province, Chinahtsc-us.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Huatai Pharma Inc., also known as Huatai Biopharm Inc., is a leading global producer and supplier of ultra-pure Omega-3 active pharmaceutical ingredients (APIs) and nutraceuticals. The company specializes in manufacturing and supplying Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) for use in cardiovascular health products, hypertriglyceridemia treatments, and general nutritional supplements globally.
- Therapeutic areas
- Metabolic DisordersCardiovascular
- Modalities
- Small moleculeLipid-based therapeuticsNutritional supplements
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Huatai Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Huatai Pharma.